Cargando…
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796653/ https://www.ncbi.nlm.nih.gov/pubmed/34758066 http://dx.doi.org/10.1182/blood.2021012589 |
| _version_ | 1784641376637419520 |
|---|---|
| author | Garcia-Manero, Guillermo Mufti, Ghulam J. Fenaux, Pierre Buckstein, Rena Santini, Valeria Díez-Campelo, María Finelli, Carlo Ilhan, Osman Sekeres, Mikkael A. Zeidan, Amer M. Ito, Rodrigo Zhang, Jennie Rampersad, Anita Sinsimer, Daniel Backstrom, Jay T. Platzbecker, Uwe Komrokji, Rami S. |
| author_facet | Garcia-Manero, Guillermo Mufti, Ghulam J. Fenaux, Pierre Buckstein, Rena Santini, Valeria Díez-Campelo, María Finelli, Carlo Ilhan, Osman Sekeres, Mikkael A. Zeidan, Amer M. Ito, Rodrigo Zhang, Jennie Rampersad, Anita Sinsimer, Daniel Backstrom, Jay T. Platzbecker, Uwe Komrokji, Rami S. |
| author_sort | Garcia-Manero, Guillermo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8796653 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87966532022-02-14 Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial Garcia-Manero, Guillermo Mufti, Ghulam J. Fenaux, Pierre Buckstein, Rena Santini, Valeria Díez-Campelo, María Finelli, Carlo Ilhan, Osman Sekeres, Mikkael A. Zeidan, Amer M. Ito, Rodrigo Zhang, Jennie Rampersad, Anita Sinsimer, Daniel Backstrom, Jay T. Platzbecker, Uwe Komrokji, Rami S. Blood Letter to Blood American Society of Hematology 2022-01-27 /pmc/articles/PMC8796653/ /pubmed/34758066 http://dx.doi.org/10.1182/blood.2021012589 Text en © 2022 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Letter to Blood Garcia-Manero, Guillermo Mufti, Ghulam J. Fenaux, Pierre Buckstein, Rena Santini, Valeria Díez-Campelo, María Finelli, Carlo Ilhan, Osman Sekeres, Mikkael A. Zeidan, Amer M. Ito, Rodrigo Zhang, Jennie Rampersad, Anita Sinsimer, Daniel Backstrom, Jay T. Platzbecker, Uwe Komrokji, Rami S. Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title | Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title_full | Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title_fullStr | Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title_full_unstemmed | Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title_short | Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial |
| title_sort | neutrophil and platelet increases with luspatercept in lower-risk mds: secondary endpoints from the medalist trial |
| topic | Letter to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796653/ https://www.ncbi.nlm.nih.gov/pubmed/34758066 http://dx.doi.org/10.1182/blood.2021012589 |
| work_keys_str_mv | AT garciamaneroguillermo neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT muftighulamj neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT fenauxpierre neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT bucksteinrena neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT santinivaleria neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT diezcampelomaria neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT finellicarlo neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT ilhanosman neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT sekeresmikkaela neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT zeidanamerm neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT itorodrigo neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT zhangjennie neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT rampersadanita neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT sinsimerdaniel neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT backstromjayt neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT platzbeckeruwe neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial AT komrokjiramis neutrophilandplateletincreaseswithluspaterceptinlowerriskmdssecondaryendpointsfromthemedalisttrial |